IDG Life Sciences to launch new magazine
03 October, 2003 by Andrew BirminghamOctober marks the culmination of our plans to develop a comprehensive suite of life science media products for the Australian market place. Australian Biotechnology News is now well entrenched as the newspaper of choice for local biotechnology leaders. And our acquisition of Today's Life Science has given us great depth across the sector.
Optiscan receives first Pentax order
03 October, 2003 by Tanya HollisOptiscan Imaging's (ASX: OIL) partnership with Japan's Pentax Corporation to develop a flexible endomicroscope has taken another step forward with the Melbourne biotech receiving its first major order for the supply of components.
ComBio: Memories are made of this
02 October, 2003 by Graeme O'NeillIt seems that memories are made of... cadherins. While cadherins -- cell adhesion molecules -- do not actually store memories, at the very least they have a major role in organising the basic architecture of the brain, and the dense filigree of fine neural interconnections in which memories are mysteriously stored.
National analytical labs to merge
25 September, 2003 by Susan WilliamsonThree major federal analytical labs are to be merged from next July, when a National Measurement Institute will be formed from the amalgamation of the National Measurement Laboratory, the National Standards Commission and the Australian Government Analytical Laboratories.
SA researchers to have better access to equipment, expertise
18 September, 2003 by Tanya HollisA new South Australian initiative aims to give scientists in that state easier access to expensive research equipment and expertise.
Brutal honesty marks Iatia's response to a tough 12 months
16 September, 2003 by Melissa TrudingerMicroscopy company Iatia (ASX:IAT) released its annual results last Friday with a brutally honest assessment of their performance over the 2002-2003 year.
Vic govt hands $20m to research institutes
11 September, 2003 by Melissa TrudingerMedical research institutes in Victoria have received an 11 per cent increase in state government infrastructure funding, with almost AUD$20 million being distributed between 20 institutes.
Q-Vis to relist on ASX on Thursday
10 September, 2003 by Melissa TrudingerSuccessful financial surgery on Australian eye-laser developer Q-Vis (ASX:QVL) will see the company reopen its eyes on the Australian Stock Exchange tomorrow, after a successful capital raising of $2.4 million.
New Austin facility a 'crucial tool'
09 September, 2003 by Melissa TrudingerA new structural biology facility, opened today at the Austin Research Institute, will be a crucial tool in understanding disease processes and will lead to real benefits for the sufferers of cancer, inflammation and other diseases, according to ARI director Prof Mark Hogarth.
Vic opposition claims synchrotron cost blow-out
05 September, 2003 by Melissa TrudingerPolitical sparring over the Australian National Synchrotron raised its head again last week, when Victoria's opposition deputy leader Phil Honeywood claimed that the project would cost the state AUD$537 million over the next decade, and called the project a white elephant.
More biotechs join S&P300 index
05 September, 2003 by Iain ScottMarket analyst Standard and Poor's has added four more Australian biotechnology firms and a medical device company to its S&P300 index.
Researchers get a preview of synchrotron-based medical opportunities
05 September, 2003 by Melissa TrudingerMore than 130 scientists and clinicians got a glimpse of synchrotron-based medicine at a recent workshop held at the Peter MacCallum Cancer Centre in Melbourne.
Cerylid regroups, lays off staff
04 September, 2003 by Melissa TrudingerUnlisted Melbourne company Cerylid Biosciences has reorganised, necessitating the layoff of a portion of its staff.
Compumedics revenues, losses up
03 September, 2003 by Melissa TrudingerCompumedics' (ASX:CMP) revenues for the 2002-2003 financial year were up 62 per cent to AUD$32 million, reflecting strong growth in the company's sleep diagnostics business.
Compumedics CEO earns entrepreneur award
26 August, 2003 by Melissa TrudingerCompumedics CEO David Burton has received an Entrepreneur of the Year award from global accounting firm Ernst and Young.
